These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31028405)

  • 1. Post-transplant Alternative Complement Pathway Activation Influences Kidney Allograft Function.
    Bartoszek D; Mazanowska O; Kościelska-Kasprzak K; Lepiesza A; Myszka M; Żabińska M; Krajewska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):171-177. PubMed ID: 31028405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Erpicum P; Weekers L; Detry O; Bonvoisin C; Delbouille MH; Grégoire C; Baudoux E; Briquet A; Lechanteur C; Maggipinto G; Somja J; Pottel H; Baron F; Jouret F; Beguin Y
    Kidney Int; 2019 Mar; 95(3):693-707. PubMed ID: 30528263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Activity of the Complement System in Deceased Donors in Relation to Kidney Allograft Outcome.
    Bartoszek D; Mazanowska O; Kościelska-Kasprzak K; Kamińska D; Lepiesza A; Chudoba P; Myszka M; Żabińska M; Klinger M
    Transplant Proc; 2018; 50(6):1697-1700. PubMed ID: 30056884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Graft Loss After Kidney Transplantation: Is "Death With Function" Really Death With a Functioning Allograft?
    Gaston RS; Fieberg A; Helgeson ES; Eversull J; Hunsicker L; Kasiske BL; Leduc R; Rush D; Matas AJ;
    Transplantation; 2020 Jul; 104(7):1483-1490. PubMed ID: 31568212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.
    Gill JS; Rose C; Joffres Y; Landsberg D; Gill J
    Am J Kidney Dis; 2018 May; 71(5):636-647. PubMed ID: 29395484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.
    Damman J; Kok JL; Snieder H; Leuvenink HG; van Goor H; Hillebrands JL; van Dijk MC; Hepkema BG; Reznichenko A; van den Born J; de Borst MH; Bakker SJ; Navis GJ; Ploeg RJ; Seelen MA
    Mol Immunol; 2012 Feb; 50(1-2):1-8. PubMed ID: 22173059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Cherukuri A; Salama AD; Carter CR; Landsittel D; Arumugakani G; Clark B; Rothstein DM; Baker RJ
    Kidney Int; 2017 Jan; 91(1):183-195. PubMed ID: 28029430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Transplantation From Old Deceased Donors: Impact of Uric Acid Level-A Quarter-Century of Experience in One Transplant Center.
    Magott-Procelewska M; Madziarska K; Boratynska M; Chudoba P; Lepiesza A; Mazanowska O; Zmonarski S; Madziarski M; Hap K; Klinger M
    Transplant Proc; 2018; 50(6):1701-1704. PubMed ID: 30056885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure.
    Cazarote HB; Shimakura S; Valdameri JS; Contieri FLC; von Glehn CQC; Aita CM; Susin MF; Sotomaior VS; Glehn-Ponsirenas R
    Transpl Immunol; 2018 Aug; 49():33-38. PubMed ID: 29596992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the IL17A and IL17F gene polymorphisms on the long-term kidney allograft function and return to dialysis after kidney transplantation.
    Romanowski M; Kłoda K; Osękowska B; Domański L; Pawlik A; Safranow K; Ciechanowski K
    Clin Transplant; 2015 Dec; 29(12):1187-94. PubMed ID: 26447633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
    PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality after Renal Allograft Failure and Return to Dialysis.
    Brar A; Markell M; Stefanov DG; Timpo E; Jindal RM; Nee R; Sumrani N; John D; Tedla F; Salifu MO
    Am J Nephrol; 2017; 45(2):180-186. PubMed ID: 28110327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.
    See EJ; Hawley CM; Cho Y; Toussaint ND; Agar JW; Pascoe EM; Lim WH; Francis RS; Collins MG; Johnson DW
    Nephrology (Carlton); 2019 Jan; 24(1):111-120. PubMed ID: 29316017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
    Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
    Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study.
    Domański L; Kłoda K; Kwiatkowska E; Borowiecka E; Safranow K; Drozd A; Ciechanowicz A; Ciechanowski K
    BMC Nephrol; 2015 Feb; 16():23. PubMed ID: 25884882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant Immune Interplay Between Donor and Recipient Influences Posttransplant Kidney Allograft Function.
    Kamińska D; Kościelska-Kasprzak K; Mazanowska O; Żabińska M; Bartoszek D; Banasik M; Chudoba P; Lepiesza A; Gomułkiewicz A; Dzięgiel P; Krajewska M; Polak W; Klinger M
    Transplant Proc; 2018; 50(6):1658-1661. PubMed ID: 30056877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Courses of Graft Failure Caused by Chronic Allograft Dysfunction in Kidney Transplantation.
    Fujiwara T; Teruta S; Tsudaka S; Ota K; Matsuda H
    Transplant Proc; 2017; 49(1):49-52. PubMed ID: 28104157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.